Vedic Ayurveda Ltd is preparing for its 45th AGM on October 30, 2026, featuring board leadership changes and a strategic pivot into the wellness sector. The company, which reported nil revenue for FY 2025-26, is actively working to revoke share trading suspension following a favorable SAT order.
Vedic Ayurveda Sets AGM for October to Finalize Strategic Pivot
- Net Loss for FY 2025-26 stands at Rs 2.10 lakh.
- Company targets transition into Ayurveda and wellness after reporting nil operational revenue.
Reader Takeaway: Management is navigating a business turnaround and regulatory compliance, but revenue generation remains the primary long-term hurdle.
What just happened
Vedic Ayurveda Ltd has scheduled its 45th Annual General Meeting (AGM) for October 30, 2026. Key agenda items include the redesignation of Ms. Deepika Awasthi as Managing Director for a five-year term and the appointment of Mr. Atul Chauhan as an Independent Director. Shareholders will also vote on resolutions to authorize borrowings and asset charges of up to Rs 100 crore.
Why this matters
The company is attempting to move past a period of inactivity. With nil revenue reported for both FY 2024-25 and FY 2025-26, the management has altered its object clause to enter the Ayurveda, herbal products, and wellness sectors. This pivot is aimed at unlocking new business opportunities to revive growth.
The backstory
Following a 2024 compulsory delisting order, the company appealed to the Securities Appellate Tribunal (SAT). A favorable order on March 17, 2026, set aside the delisting, and the company is now in the process of applying to the BSE to revoke the suspension of its equity shares.
Risks to watch
Statutory auditors have issued a qualified opinion. Concerns include the lack of confirmation for closing balances of loans and advances, and the company's failure to file Income Tax Returns since the 2021-22 assessment year. Management has stated that the firm was inoperative during these periods and is working to rectify these regulatory lapses.
What to track next
Investors should closely monitor the BSE's decision regarding the revocation of the trading suspension. Additionally, the execution of the new wellness-focused business strategy will be critical, as the company currently maintains a lean structure with only three employees.